AI, Biomarkers and the Future of Longevity Medicine, with Elio Verhoef, Co-Founder of LongevAI

In this episode, Daphna sits down with Elio, co-founder of LongevAI, a platform using artificial intelligence to help longevity clinics analyse biomarker data, streamline documentation, and build personalised client plans.

With a background in computer science and a lifelong passion for health optimisation, Elio offers a grounded, honest perspective on what AI in longevity medicine can do today, and where the limits still lie.

______________

What We Cover

• How LongevAI was founded and what problem it solves for longevity clinics

• What it means to automate clinical documentation without removing the clinician from the process

• How AI interprets biomarker data, and why speed and accuracy both play a role

• The hallucination problem: what it is, why it happens, and how it is being managed

• Data privacy, GDPR compliance, and anonymisation in clinical AI tools

• The importance of human oversight, why the clinician must always approve before anything reaches the client

• How AI and clinicians can learn from each other in a feedback loop

• Wearable integration and the role of continuous vs snapshot data

• Where AI in longevity is heading in two to five years, including gene therapy modelling and whole-cell simulation

• Why younger people are beginning to engage with longevity, and what still holds them back

About the Guest

Elio is the co-founder of LongevAI, a software platform built for longevity clinics. He holds a double bachelor's degree in Computer Science and Information Science, and has been focused on health optimisation and AI since his teens. He co-founded LongevAI in December 2024 alongside Cosmina Druica, whom he met through a longevity meetup community in the Netherlands.

🔗 longevai.com

Enjoyed this episode? Please subscribe, leave a review on Apple Podcasts or Spotify, and share with anyone curious about the future of longevity medicine.

Beyond Longevity is hosted by Daphna Stern · beyond-longevity.co.uk

In this episode:

00:00 Welcome and Guest Intro

01:52 Elio Background and Origins

04:01 What Lev AI Does

05:06 Automating Clinic Workflows

07:52 Speed vs Accuracy

11:45 Oversight and Patient Trust

12:57 Privacy and GDPR Security

13:56 How the Model Improves

15:06 Limits Data and Hallucinations

21:37 Training and Integrations

23:45 Personal Biomarker Walkthrough

28:34 Explaining LLMs to non-tech people

33:38 Future of AI and Longevity

35:32 Young People and Longevity

39:56 Rapid Fire Questions

43:45 Wrap Up and Key Takeaways

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(37)

Can You Do Too Much for Your Health? Biological Age, NAD+ and Longevity Hype

Longevity medicine has created a strange new kind of patient: the healthy person convinced something must be wrong.A wearable flags poor recovery. One test says your body is ageing faster than it shou...

20 Sep 1h

Can a Supplement Actually Slow Ageing? NOVOS Founder Chris Mirabile on Tackling All 12 Hallmarks

At 16, Chris Mirabile was lying in a hospital bed the night before brain surgery, wondering whether he would wake up the next morning. Years later, as he was building NOVOS, he lost his mother to panc...

13 Sep 1h 14min

Beyond Longevity at HLTH Europe Part Two: Microbiomes, Breath Diagnostics and the Future of Medical AI

Recorded at HLTH Europe in Amsterdam, Part Two of our special series looks at four very different ways technology could help healthcare move earlier, become more personalised and make better use of th...

6 Sep 57min

Beyond Longevity at HLTH Europe: Wearables, AI and Remote Rehabilitation for Preventive Health

What happens when technology stops simply tracking our health and starts helping us understand what to do about it?Recorded at HLTH Europe in Amsterdam, this episode of Beyond Longevity features three...

30 Aug 42min

Can a Senolytic Vaccine Slow Ageing? Dr David Scieszka on Senescent Cells and Longevity

What if a vaccine could help the immune system clear senescent “zombie” cells — damaged cells linked to ageing, chronic inflammation and age-related disease?In this episode of Beyond Longevity, Daphna...

23 Aug 56min

Can One Drug Slow Ageing Across the Whole Body? LinkGevity’s Bid to Block Necrosis

What if heart disease, kidney disease and dementia share a common mechanism linked to ageing? And what if blocking a destructive form of cell death called necrosis could help protect several organs at...

16 Aug 1h 6min

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

At 39, Leslie Kenny was diagnosed with rheumatoid arthritis and lupus and says she was told she had around five years to live. More than two decades later, she is in long-term remission and has turned...

9 Aug 59min

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy...

2 Aug 48min